258 related articles for article (PubMed ID: 21857030)
1. Quantitative phospho-proteomics to investigate the polo-like kinase 1-dependent phospho-proteome.
Grosstessner-Hain K; Hegemann B; Novatchkova M; Rameseder J; Joughin BA; Hudecz O; Roitinger E; Pichler P; Kraut N; Yaffe MB; Peters JM; Mechtler K
Mol Cell Proteomics; 2011 Nov; 10(11):M111.008540. PubMed ID: 21857030
[TBL] [Abstract][Full Text] [Related]
2. The Plk1-dependent phosphoproteome of the early mitotic spindle.
Santamaria A; Wang B; Elowe S; Malik R; Zhang F; Bauer M; Schmidt A; Silljé HH; Körner R; Nigg EA
Mol Cell Proteomics; 2011 Jan; 10(1):M110.004457. PubMed ID: 20860994
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions.
Bibi N; Parveen Z; Rashid S
PLoS One; 2013; 8(8):e70843. PubMed ID: 23967120
[TBL] [Abstract][Full Text] [Related]
4. Large-scale label-free comparative proteomics analysis of polo-like kinase 1 inhibition via the small-molecule inhibitor BI 6727 (Volasertib) in BRAF(V600E) mutant melanoma cells.
Cholewa BD; Pellitteri-Hahn MC; Scarlett CO; Ahmad N
J Proteome Res; 2014 Nov; 13(11):5041-50. PubMed ID: 24884503
[TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus.
Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Menendez JA
Cell Cycle; 2011 Apr; 10(8):1295-302. PubMed ID: 21474997
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase controls vertebrate spindle elongation and cytokinesis.
Brennan IM; Peters U; Kapoor TM; Straight AF
PLoS One; 2007 May; 2(5):e409. PubMed ID: 17476331
[TBL] [Abstract][Full Text] [Related]
7. Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1.
Raab M; Krämer A; Hehlgans S; Sanhaji M; Kurunci-Csacsko E; Dötsch C; Bug G; Ottmann O; Becker S; Pachl F; Kuster B; Strebhardt K
Mol Oncol; 2015 Jan; 9(1):140-54. PubMed ID: 25169932
[TBL] [Abstract][Full Text] [Related]
8. A cryptic hydrophobic pocket in the polo-box domain of the polo-like kinase PLK1 regulates substrate recognition and mitotic chromosome segregation.
Sharma P; Mahen R; Rossmann M; Stokes JE; Hardwick B; Huggins DJ; Emery A; Kunciw DL; Hyvönen M; Spring DR; McKenzie GJ; Venkitaraman AR
Sci Rep; 2019 Nov; 9(1):15930. PubMed ID: 31685831
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.
Valianou M; Cox AM; Pichette B; Hartley S; Paladhi UR; Astrinidis A
Cell Cycle; 2015; 14(3):399-407. PubMed ID: 25565629
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions.
Reindl W; Yuan J; Krämer A; Strebhardt K; Berg T
Chem Biol; 2008 May; 15(5):459-66. PubMed ID: 18482698
[TBL] [Abstract][Full Text] [Related]
11. Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain.
Shin SB; Woo SU; Yim H
J Cell Physiol; 2015 Dec; 230(12):3057-67. PubMed ID: 25975351
[TBL] [Abstract][Full Text] [Related]
12. Designed inhibitor for nuclear localization signal of polo-like kinase 1 induces mitotic arrest.
Chen F; Zhuo X; Qin T; Guo X; Zhang C; Lai L
Chem Biol Drug Des; 2017 May; 89(5):732-740. PubMed ID: 27882722
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.
Golsteyn RM; Mundt KE; Fry AM; Nigg EA
J Cell Biol; 1995 Jun; 129(6):1617-28. PubMed ID: 7790358
[TBL] [Abstract][Full Text] [Related]
14. Requirements for protein phosphorylation and the kinase activity of polo-like kinase 1 (Plk1) for the kinetochore function of mitotic arrest deficiency protein 1 (Mad1).
Chi YH; Haller K; Ward MD; Semmes OJ; Li Y; Jeang KT
J Biol Chem; 2008 Dec; 283(51):35834-44. PubMed ID: 18922800
[TBL] [Abstract][Full Text] [Related]
15. p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors.
Sanhaji M; Kreis NN; Zimmer B; Berg T; Louwen F; Yuan J
Cell Cycle; 2012 Feb; 11(3):543-53. PubMed ID: 22262171
[TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochores.
Ahonen LJ; Kallio MJ; Daum JR; Bolton M; Manke IA; Yaffe MB; Stukenberg PT; Gorbsky GJ
Curr Biol; 2005 Jun; 15(12):1078-89. PubMed ID: 15964272
[TBL] [Abstract][Full Text] [Related]
17. Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrate.
Lowery DM; Clauser KR; Hjerrild M; Lim D; Alexander J; Kishi K; Ong SE; Gammeltoft S; Carr SA; Yaffe MB
EMBO J; 2007 May; 26(9):2262-73. PubMed ID: 17446864
[TBL] [Abstract][Full Text] [Related]
18. The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1.
Lénárt P; Petronczki M; Steegmaier M; Di Fiore B; Lipp JJ; Hoffmann M; Rettig WJ; Kraut N; Peters JM
Curr Biol; 2007 Feb; 17(4):304-15. PubMed ID: 17291761
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors.
Lin TY; Min HP; Jiang C; Niu MM; Yan F; Xu LL; Di B
Bioorg Med Chem; 2018 Jul; 26(12):3429-3437. PubMed ID: 29807699
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of Hsp70 as a new Plk1 substrate in arsenic trioxide-induced mitotically arrested cells.
Chen YJ; Lin YP; Chow LP; Lee TC
Proteomics; 2011 Nov; 11(22):4331-45. PubMed ID: 21887822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]